New insights into drug resistance in cancer.
暂无分享,去创建一个
[1] T. Fojo,et al. Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization* , 1997, The Journal of Biological Chemistry.
[2] T. Fojo,et al. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] D. Panda,et al. Microtubule dynamics in vitro are regulated by the tubulin isotype composition. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] E. Nogales,et al. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] W. Mellado,et al. Taxol: Mechanisms of Action and Resistance a , 1986, Journal of the National Cancer Institute. Monographs.
[6] M. Kavallaris,et al. Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions. , 2003, Chemistry & biology.
[7] M. Kavallaris,et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. , 1997, The Journal of clinical investigation.
[8] S. Kuduk,et al. A common pharmacophore for cytotoxic natural products that stabilize microtubules. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Sullivan,et al. Molecular biology and genetics of tubulin. , 1985, Annual review of biochemistry.
[10] E. Nogales,et al. Refined structure of alpha beta-tubulin at 3.5 A resolution. , 2001, Journal of molecular biology.